相关实验视频
Updated: Jun 7, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.6K
合成一个小库的SGLT1的糖衍生物假定体和初步的生物学评估
Giuseppe D'Orazio1, Barbara La Ferla2
1Department of Chemistry, Università degli Studi di Milano, Via C. Golgi 19, 20133 Milan, Italy.
Molecules (Basel, Switzerland)
|November 9, 2024
概括
研究人员探索了针对-葡萄糖辅运输体1 (SGLT1) 的新型C-糖化物,以了解其对肠道屏障的抗炎作用. 这些化合物的芳香部分是活性的关键,为新的治疗铺平了道路.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- -葡萄糖共运输体1 (SGLT1) 促进肠细胞中葡萄糖的吸收,并保护肠道屏障的完整性.
- D-葡萄糖和合成的C-葡萄糖体对肠道上皮具有保护性,抗炎作用.
- 目前尚不清楚SGLT1的保护作用的确切机制.
研究的目的:
- 合成C-糖化物化合物的库作为潜在的SGLT1配体.
- 研究这些化合物的结构-活性关系.
- 阐明SGLT1介导的肠道保护的机制.
主要方法:
- 一个小库的C-糖酸衍生物的合成.
- 在实验室评估使用多克索鲁比诱导的粘膜炎模型.
- 评估生物活性和结构-活性关系.
主要成果:
- 所有合成的C-糖化物在体外模型中都表现出生物活性.
- 鉴定出C-糖酸的芳香部分对于抗炎活性至关重要.
- 糖成分对观察到的生物效应的影响较小.
结论:
- 芳香组对于SGLT1配体的抗炎活性至关重要.
- 这些发现为开发针对SGLT1.1的新型抗炎药物提供了基础.
- 进一步的研究将专注于优化化合物的功效和了解保护机制.
相关概念视频
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Oral Hypoglycemic Agents: Sulfonylureas
192
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
192
Dipeptidyl Peptidase 4 Inhibitors
172
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
172
Secondary Active Transport
6.9K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.9K
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
